CONCLUSION: Our results reveal a role of YY1 involved in neutrophils infiltration in RA via a PI3K/Akt/mTOR/IL-8 signaling pathway. YY1 may be a new therapeutic target for treatment of RA. This article is protected by copyright. All rights reserved. PMID: 30229869 [PubMed - as supplied by publisher] (Source: Clinical and Developmental Immunology)
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2OBpGkC
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.